1. Home
  2. FARM vs XLO Comparison

FARM vs XLO Comparison

Compare FARM & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmer Brothers Company

FARM

Farmer Brothers Company

HOLD

Current Price

$1.23

Market Cap

26.9M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.50

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FARM
XLO
Founded
1912
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.9M
39.4M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
FARM
XLO
Price
$1.23
$0.50
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$2.75
$2.00
AVG Volume (30 Days)
329.5K
441.7K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.79
EPS
N/A
N/A
Revenue
$342,281,000.00
$6,344,000.00
Revenue This Year
$2.66
$626.78
Revenue Next Year
$2.11
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
0.35
N/A
52 Week Low
$1.22
$0.46
52 Week High
$2.38
$1.18

Technical Indicators

Market Signals
Indicator
FARM
XLO
Relative Strength Index (RSI) 25.70 34.34
Support Level N/A N/A
Resistance Level $1.59 $0.74
Average True Range (ATR) 0.05 0.04
MACD -0.02 -0.00
Stochastic Oscillator 1.52 31.21

Price Performance

Historical Comparison
FARM
XLO

About FARM Farmer Brothers Company

Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: